Evidence map›Paper›PMID 31554959›Full record

ReviewThe Journal of antibiotics2019

Discovery and applications of nucleoside antibiotics beyond polyoxin.

Hiroyuki Osada

Abstract readReview
PubMed Publisher
In one paragraph

Review in The Journal of antibiotics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biological efficacy of polyoxin D in crop protection.Journal of pesticide science · 2025
    Article
  7. Review
  8. Chemical biology research in RIKEN NPDepo aimed at agricultural applications.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2025
    Review
  9. Article
  10. New Biocides Based onInternational journal of molecular sciences · 2024
    Article
  11. EndophyticMicroorganisms · 2022
    Review
  12. Antibacterial Activity of Aureonuclemycin Produced byMolecules (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Hiroyuki OsadaChemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Hirosawa 2-1, Wako-shi, Saitama, 351-0198, Japan. cb-secretary@ml.riken.jp.ORCID http://orcid.org/0000-0002-3606-4925
RIKEN Center for Sustainable Resource Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleoside antibiotics possess various biological activities such as antibacterial, antifungal, anticancer, and herbicidal activities. RIKEN scientists contributed to this area of research with two representative antifungal nucleoside antibiotics, blasticidin S and polyoxin. Blasticidin S was the first antibiotic exploited in agriculture worldwide. Meanwhile, the polyoxins discovered by Isono and Suzuki are still used globally as an agricultural antibiotic. In this review article, the research on nucleoside antibiotics mainly done by Isono and his collaborators is summarized from the discovery of polyoxin to subsequent investigations.

Indexed as

AdenosineAminoglycosidesAnti-Bacterial AgentsAzepinesCell WallDrug DiscoveryFungicides, IndustrialGuanineNucleosidesProtein Kinase InhibitorsPurine NucleotidesPyrimidine NucleosidesRibonucleosidesUridineAdenosineAminoglycosidesAnti-Bacterial AgentsascamycinAzepinescaprazamycin AFungicides, IndustrialGuanineguanine 7-oxideliposidomycinsneopolyoxin AnikkomycinNucleosidesphosmidosinepolyoxinProtein Kinase InhibitorsPurine NucleotidesPyrimidine NucleosidesRibonucleosidesUridine

Identifiers

PMID31554959
OpenAlexW2976926339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.